Walleye Trading LLC Agios Pharmaceuticals, Inc. Call Options Transaction History

Walleye Trading LLC

$46.7 Billion
Q3 2024

Call Options

18 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2023 Nov 14, 2023	BUY	$24.36 - $28.18 $248,472 - $287,436	10,200 New	10,200 $252,000
Q3 2022 Nov 14, 2022	BUY	$19.51 - $34.14 $282,895 - $495,030	14,500 New	14,500 $410,000
Q2 2022 Aug 08, 2022	SELL	$17.06 - $31.42 $102,359 - $188,520	-6,000 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$26.68 - $34.81 $37,352 - $48,734	-1,400 Reduced 18.92%	6,000 $175,000
Q4 2021 Feb 14, 2022	SELL	$29.58 - $49.78 $118,320 - $199,120	-4,000 Reduced 35.09%	7,400 $243,000
Q3 2021 Nov 15, 2021	BUY	$41.92 - $58.18 $477,888 - $663,252	11,400 New	11,400 $526,000
Q1 2021 May 17, 2021	SELL	$44.23 - $57.5 $8,846 - $11,500	-200 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$33.21 - $46.54 $6,642 - $9,308	200 New	200 $9,000
Q3 2020 Nov 16, 2020	SELL	$33.87 - $55.93 $1.28 Million - $2.12 Million	-37,900 Closed	0 $0
Q2 2020 Aug 14, 2020	SELL	$34.45 - $53.48 $2.02 Million - $3.14 Million	-58,700 Reduced 60.77%	37,900 $2.03 Million
Q1 2020 May 15, 2020	SELL	$31.52 - $53.81 $535,840 - $914,770	-17,000 Reduced 14.96%	96,600 $3.43 Million
Q4 2019 Feb 14, 2020	BUY	$30.08 - $50.59 $2.9 Million - $4.88 Million	96,500 Added 564.33%	113,600 $5.42 Million
Q3 2019 Nov 14, 2019	SELL	$32.4 - $49.58 $567,000 - $867,650	-17,500 Reduced 50.58%	17,100 $554,000
Q2 2019 Aug 14, 2019	BUY	$46.17 - $68.1 $960,336 - $1.42 Million	20,800 Added 150.72%	34,600 $1.73 Million
Q1 2019 May 15, 2019	BUY	$45.92 - $67.67 $142,352 - $209,777	3,100 Added 28.97%	13,800 $931,000
Q4 2018 Feb 14, 2019	SELL	$42.73 - $76.53 $311,929 - $558,669	-7,300 Reduced 40.56%	10,700 $493,000
Q3 2018 Nov 14, 2018	BUY	$71.67 - $91.95 $838,539 - $1.08 Million	11,700 Added 185.71%	18,000 $1.39 Million
Q2 2018 Aug 14, 2018	BUY	$73.22 - $99.55 $461,286 - $627,165	6,300 New	6,300 $531,000

Others Institutions Holding AGIO

# of Institutions

232

Shares Held

58.1M

Call Options Held

403K

Put Options Held

469K

Farallon Capital Management LLC San Francisco, CA

5.66M
Shares

$315 Million
1.26% of portfolio
Vanguard Group Inc Valley Forge, PA

5.55M
Shares

$309 Million
0.0% of portfolio
Black Rock Inc. New York, NY

4.86M
Shares

$271 Million
0.0% of portfolio
Bellevue Group Ag Kuesnacht, V8

3.74M
Shares

$208 Million
2.8% of portfolio
Price T Rowe Associates Inc Baltimore, MD

2.83M
Shares

$158 Million
0.01% of portfolio

View Full List

About AGIOS PHARMACEUTICALS, INC.

Ticker AGIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 54,818,000
Market Cap $3.05B
Description
Agios Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of medicines in the field of cellular metabolism and adjacent areas of biology. The company offers PYRUKYND (mitapivat) an activator of both wild-type and a variety of mutant pyruvate kinase, PK, enzymes for the treatment of hemolytic anemias; and ...

More about AGIO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Walleye Trading LLC, based on Form 13F filings with the SEC.

News

Stay updated on Walleye Trading LLC with notifications on news.

Account